Epidemiologic Trends in Pediatric Lead Poisoning at Freestanding Children's Hospitals, 2016-2023

Phillip D Hahn1, Carly E Milliren2, Diane Story3,4

  • 1Program for Patient Safety and Quality, Boston Children's Hospital, Boston, Massachusetts.

Hospital Pediatrics
|December 16, 2025
PubMed

Insights

Severe childhood lead poisoning remains a significant public health issue in the US. Higher encounter rates were observed in minority children, those with public insurance, and those in rural or low-opportunity areas.

Area of Science:

  • Pediatric Health
  • Epidemiology
  • Environmental Health

Background:

  • Elevated blood lead levels are a persistent concern for children's health in the US.
  • Severe childhood lead poisoning cases continue to be reported nationwide.
  • The epidemiology of hospital encounters for severe lead poisoning was previously unknown.

Purpose of the Study:

  • To investigate the epidemiology of hospital encounters for severe childhood lead poisoning.
  • To identify sociodemographic disparities in lead poisoning hospitalizations and emergency department visits.

Main Methods:

  • Utilized Pediatric Hospital Information System data from 2016 to 2023.
  • Included children with a primary diagnosis of lead poisoning.
  • Employed descriptive statistics and Poisson regression to analyze patient characteristics and encounter rates by race, ethnicity, insurance, urbanicity, and Childhood Opportunity Index (COI).

Main Results:

  • Analyzed 845 inpatient and 1137 emergency department encounters, totaling over $4.5 million in annual billed charges.
  • Found significantly higher lead poisoning encounter rates among Asian, Black, and multiracial non-Hispanic children compared to white non-Hispanic children.
  • Observed higher rates in children with public insurance, those in rural zip codes, and those residing in low and very low Childhood Opportunity Index (COI) areas.

Conclusions:

  • Severe lead poisoning represents a substantial ongoing health problem.
  • Significant disparities in lead poisoning encounter rates exist based on sociodemographic factors.
  • These findings highlight the need for targeted interventions to address lead poisoning inequities.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
231
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K